Eveline Nüesch - Publications, H-index & Citations

Eveline Nüesch

swedish orphan biovitrum

48H指数

163论文数

1.0W被引数

收录论文 50

发表时间

A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia A A-SURE：重组凝血因子VIII Fc融合蛋白与标准半衰期凝血因子VIII在血友病A中的预防性治疗效果的个体内比较

Hematology

IF1.6

2025-12-31

PREAI

Oldenburg, Johannes; Hay, Charles; Peyvandi, Flora; Lehtinen, Anna-Elina; Pabinger, Ingrid; Nuesch, Eveline; Malmstrom, Hakan; Bednar, Eva; Lethagen, Stefan

Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)

BMC CANCER

IF3.4

2025-03-18

OAAI

Marbach, Daniel; Brouer-Visser, Jurriaan; Brennan, Laura; Wilson, Sabine; Davydov, Iakov I.; Staedler, Nicolas; Duarte, Jose; Quetglas, Iris Martinez; Nueesch, Eveline; Canamero, Marta; Chesne, Evelyne; Au-Yeung, George; Hamilton, Erika; Lheureux, Stephanie; Richardson, Debra L.; Spanggaard, Iben; Gomes, Bruno; Franjkovic, Izolda; Demario, Mark; Kornacker, Martin; Lechner, Katharina

Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in France

THERAPEUTIC ADVANCES IN HEMATOLOGY

IF3.1

2025-01-26

OAAI

Chambost, Herve; Repesse, Yohann; Genre-Volot, Fabienne; Desprez, Dominique; Castet, Sabine Marie; Vanderbecken, Stephane; Zidi, Meriem; Gandossi, Corinne; Nuesch, Eveline; Palmborg, Helena; Santagostino, Elena

Real-world usage and effectiveness of recombinant factor VIII/ factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2024-07-01

OAAI

Bidlingmaier, Christoph; Heller, Christine; Langer, Florian; Miesbach, Wolfgang; Scholz, Ute; Oldenburg, Johannes; Nueesch, Eveline; Palmborg, Helena; Santagostino, Elena; Tiede, Andreas

A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2023-05-10

PREAI

Melero, Ignacio; Tanos, Tamara; Bustamante, Mariana; Sanmamed, Miguel F.; Calvo, Emiliano; Moreno, Irene; Moreno, Victor; Hernandez, Tatiana; Garcia, Maria Martinez; Rodriguez-Vida, Alejo; Tabernero, Josep; Azaro, Analia; Ponz-Sarvise, Mariano; Spanggaard, Iben; Rohrberg, Kristoffer; Guarin, Ernesto; Nuesch, Eveline; Davydov, Iakov I.; Ooi, Chiahuey; Duarte, Jose; Chesne, Evelyne; McIntyre, Christine; Ceppi, Maurizio; Canamero, Marta; Krieter, Oliver

T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-04-27

OAAI

Brennan, Laura; Brouwer-Visser, Jurriaan; Nueesch, Eveline; Karpova, Maria; Heller, Astrid; Gaire, Fabien; Schneider, Meike; Gomes, Bruno; Korski, Konstanty

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

BLOOD ADVANCES

IF7.1

2021-11-22

OAAI

Dickinson, Michael; Briones, Javier; Herrera, Alex F.; Gonzalez-Barca, Eva; Ghosh, Nilanjan; Cordoba, Raul; Rutherford, Sarah C.; Bournazou, Eirini; Labriola-Tompkins, Emily; Franjkovic, Izolda; Chesne, Evelyne; Brouwer-Visser, Jurriaan; Lechner, Katharina; Brennan, Barbara; Nueesch, Eveline; DeMario, Mark; Ruettinger, Dominik; Kornacker, Martin; Hutchings, Martin

Changes in patient, tumor, and treatment characteristics over time in first-line trastuzumab plus taxane (paclitaxel/docetaxel) arms in HER2-positive metastatic breast cancer trials

CANCER RESEARCH

IF16.6

2019-02-15

PREAI

Crnjevic, T. Badovinac; Restuccia, E.; Michielin, F.; Eng-Wong, J.; Nuesch, E.

A real-world study of cardiac events in >3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study

BREAST CANCER RESEARCH AND TREATMENT

IF3

2018-11-30

OAAI

Lidbrink, Elisabet; Chmielowska, E.; Otremba, B.; Bouhlel, A.; Lauer, S.; Hermoso, M. Liste; Nuesch, E.; Shing, M.; Misra, V.

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK plus ) non-small-cell lung cancer: CNS efficacy results from the ALEX study

ANNALS OF ONCOLOGY

IF65.4

2018-11-01

242

OAAI

Gadgeel, S.; Peters, S.; Mok, T.; Shaw, A. T.; Kim, D. W.; Ou, S. I.; Perol, M.; Wrona, A.; Novello, S.; Rosell, R.; Zeaiter, A.; Liu, T.; Nuesch, E.; Balas, B.; Camidge, D. R.

Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer 长期曲妥珠单抗 (赫赛汀®) 在HER2-positive乳腺癌或HER2-positive胃癌患者的继续研究中的治疗

BMC CANCER

IF3.4

2018-03-15

OAAI

Mueller, Volkmar; Clemens, Michael; Jassem, Jacek; Al-Sakaff, Nedal; Auclair, Petra; Nuesch, Eveline; Holloway, Debbie; Shing, Mona; Bang, Yung-Jue

Incident disability in older adults: prediction models based on two British prospective cohort studies

AGE AND AGEING

IF7.1

2014-10-27

OAAI

Nueesch, Eveline; Pablo, Perel; Dale, Caroline E.; Prieto-Merino, David; Kumari, Meena; Bowling, Ann; Ebrahim, Shah; Casas, Juan P.

Fractional Flow Reserve-Guided PCI for Stable Coronary Artery Disease

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2014-09-25

886

OAAI

De Bruyne, Bernard; Fearon, William F.; Pijls, Nico H. J.; Barbato, Emanuele; Tonino, Pim; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Rioufol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engstroem, Thomas; Oldroyd, Keith; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B.; Limacher, Andreas; Nueesch, Eveline; Jueni, Peter

Oral or transdermal opioids for osteoarthritis of the knee or hip

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2014-09-17

147

OAAI

da Costa, Bruno R.; Nueesch, Eveline; Kasteler, Rahel; Husni, Elaine; Welch, Vivian; Rutjes, Anne W. S.; Jueni, Peter

Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2013-08-01

PREAI